miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment

被引:0
|
作者
Anajafi, Sara [1 ]
Paryan, Mahdi [2 ]
Khoshnazar, Amineh [1 ]
Soleimani, Masoud [3 ]
Mohammadi-Yeganeh, Samira [1 ,3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Tehran, Iran
[2] Pasteur Inst Iran, Dept Res & Dev, Prod & Res Complex, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Med Nanotechnol & Tissue Engn Res Ctr, Tehran, Iran
关键词
miRNA; cancer-associated fibroblasts (CAF); tumor microenvironment; signaling pathways; drug delivery; drug resistance; PARACRINE TGF-BETA; TUMOR MICROENVIRONMENT; CISPLATIN RESISTANCE; EXPRESSION ANALYSIS; ANTICANCER DRUGS; PANCREATIC TUMOR; CELL-MIGRATION; LUNG-CANCER; STEM-CELLS; PROMOTE;
D O I
10.2174/1871530323666230823094556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cancer-associated fibroblasts (CAFs) as a major component of cancer stroma contribute to diverse procedures of most solid tumors and might be a targeted cancer therapy approach. Their specified features, related signaling pathways, distinct biomarkers, and sub-populations need to be deciphered. There is a need for CAF extraction or induction for in vitro investigations. Some miRNAs could activate CAF-like phenotype and they also interfere in CAF-mediated drug resistance, aggressiveness, and metastatic behaviors of several cancer cell types. Due to the complex relevance of miRNA and CAFs, these non-coding oligonucleotides may serve as attractive scope for anti-cancer targeted therapies, but the lack of an efficient delivery system is still a major hurdle. Here, we have summarized the investigated information on CAF features, isolation, and induction procedures, and highlighted the miRNA-CAF communications, providing special insight into nano-delivery systems.
引用
收藏
页码:333 / 347
页数:15
相关论文
共 50 条
  • [21] Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer
    Shinkawa, Tomohiko
    Ohuchida, Kenoki
    Nakamura, Masafumi
    CANCERS, 2022, 14 (16)
  • [22] Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance
    Kazakova, Anastasia N.
    Lukina, Maria M.
    Anufrieva, Ksenia S.
    Bekbaeva, Irina V.
    Ivanova, Olga M.
    Shnaider, Polina V.
    Slonov, Andrey
    Arapidi, Georgij P.
    Shender, Victoria O.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [23] Targeting and Reprograming Cancer-Associated Fibroblasts and the Tumor Microenvironment in Pancreatic Cancer
    Sunami, Yoshiaki
    Boeker, Viktoria
    Kleeff, Joerg
    CANCERS, 2021, 13 (04) : 1 - 14
  • [25] miR-200 inhibits the activation of cancer-associated fibroblasts in lung tumor microenvironment
    Cheon, Inyoung
    Lee, Sieun
    CANCER RESEARCH, 2023, 83 (07)
  • [26] Ligustilide inhibits the activation of cancer-associated fibroblasts
    Ma, Jing
    Xu, Yuwei
    Zheng, Qilin
    Wang, Yuanyuan
    Hu, Minghua
    Ma, Fangli
    Long, Hanan
    Qin, Zhihai
    Tao, Ning
    LIFE SCIENCES, 2019, 218 : 58 - 64
  • [27] Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts
    Liu, Huiqin
    Shi, Yu
    Qian, Feng
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 172 : 37 - 51
  • [28] Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer
    Wang, Wenyu
    Cheng, Bing
    Yu, Qiang
    CANCER DRUG RESISTANCE, 2022, 5 (04) : 889 - 901
  • [29] Role of cancer-associated fibroblasts in tumor structure, composition and the microenvironment in ovarian cancer
    Sun, Wei
    Fu, Shilong
    ONCOLOGY LETTERS, 2019, 18 (03) : 2173 - 2178
  • [30] The role of tumor microenvironment and cancer-associated fibroblasts in breast cancer development and progression
    Ramirez-Farias, Cynthia
    Gonzalez-Blas, Daniel
    Quintanar-Stephano, Andres
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2023, 36 (02):